Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 69 checked references that resolve
resolves10.1126/science.7678351Tumor Rejection After Direct Costimulation of CD8
<sup>+</sup>
T Cells by B7-Transfected Melanoma Cells
resolves10.1073/pnas.92.18.8200Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.
resolves10.4049/jimmunol.164.5.2285TGF-β1 Reciprocally Controls Chemotaxis of Human Peripheral Blood Monocyte-Derived Dendritic Cells Via Chemokine Receptors
resolves10.1182/blood.V99.7.2468CD4+ and CD8+ anergic T cells induced by interleukin-10–treated human dendritic cells display antigen-specific suppressor activity
resolves10.1038/nm1096-1096Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
resolves10.4049/jimmunol.159.1.28IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells
resolves10.4049/jimmunol.166.3.1650Prostaglandin E2 Up-Regulates Macrophage-Derived Chemokine Production but Suppresses IFN-Inducible Protein-10 Production by APC
resolves10.1182/blood-2001-12-0360Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets
resolves10.1038/nri1498Mechanisms and functional significance of tumour-induced dendritic-cell defects
resolves10.1080/10428190500360971Dendritic cells are significantly reduced in non-Hodgkin's lymphoma and express less CCR7 and CD62L
resolves10.1038/nm976Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
resolves10.1038/nri1457Ido expression by dendritic cells: tolerance and tryptophan catabolism
resolves10.1038/nm934Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
resolves10.1038/nm1196Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
resolves10.1172/JCI21583Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
resolves10.4049/jimmunol.164.7.3596Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation
resolves10.1126/science.1073514Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
resolves10.4049/jimmunol.172.7.4100Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells
resolves10.1084/jem.20020052Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells
resolves10.4049/jimmunol.165.3.1357IFN-γ Inhibits Presentation of a Tumor/Self Peptide by CD8α− Dendritic Cells Via Potentiation of the CD8α+ Subset
resolves10.1093/intimm/14.1.65Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells
resolves10.4049/jimmunol.171.4.1652Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion
resolves10.1016/j.steroids.2004.05.019Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis
resolves10.1182/blood-2005-03-0979A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
resolves10.4049/jimmunol.175.3.1483Prostaglandin E2 Induces
<i>FOXP3</i>
Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells
resolves10.1158/0008-5472.CAN-05-0141Tumor Cyclooxygenase-2/Prostaglandin E2–Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer
resolves10.1074/jbc.M010787200Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
resolves10.1172/JCI16492Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor
resolves10.1126/science.1116221Prostaglandin E
<sub>2</sub>
Promotes Colon Cancer Cell Growth Through a G
<sub>s</sub>
-Axin-ß-Catenin Signaling Axis
resolves10.1182/blood.V97.11.3466Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer
resolves10.4049/jimmunol.168.5.2255Cyclooxygenase-2-Issued Prostaglandin E2 Enhances the Production of Endogenous IL-10, Which Down-Regulates Dendritic Cell Functions
resolves10.1182/blood-2001-11-0017Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
resolves10.1182/blood-2003-05-1643CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
resolves10.1002/eji.1830271209Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions
resolves10.1084/jem.179.4.1109Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
resolves10.1038/sj.tpj.6500240Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types
resolves10.1074/jbc.M105517200Major Histocompatibility Complex Class I-presented Antigenic Peptides Are Degraded in Cytosolic Extracts Primarily by Thimet Oligopeptidase
resolves10.4049/jimmunol.173.2.945SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation
resolves10.4049/jimmunol.161.6.2804Prostaglandin E2 Induces the Final Maturation of IL-12-Deficient CD1a+CD83+ Dendritic Cells: The Levels of IL-12 Are Determined During the Final Dendritic Cell Maturation and Are Resistant to Further Modulation
resolves10.4049/jimmunol.148.9.2845Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R α gene expression at multiple levels
resolves10.1084/jem.183.4.1587Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.
resolves10.4049/jimmunol.131.2.690Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
resolves10.3109/08820138909045783Soluble Interleukin 2 Receptors Released from Mitogen Stimulated Human Peripheral Blood Lymphocytes Bind Interleukin 2 and Inhibit IL2 Dependent Cell Proliferation
resolves10.4049/jimmunol.165.11.6037BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood
resolves10.1093/intimm/10.2.237Does the IL-2 receptor alpha chain induced on dendritic cells have a biological function?
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.